Skip to main content

Transparency, trust, and community welfare: towards a precision public health ethics framework for the genomics era


Infectious disease control is experiencing a paradigm shift, as pathogen sequencing technologies and digital applications are increasingly implemented for control of diseases such as tuberculosis, Ebola, and COVID-19. A new ethical framework should be a critical part of this emerging paradigm to ensure that the benefit of precision public health interventions based on advances in genomics research is not outweighed by the risks they pose to individuals, families, and vulnerable segments of the population. We suggest that the ethical framework guiding practice in this domain combines standard precepts from public health ethics with emerging ethics principles from precision medicine.

Precision public health

Precision public health was first defined by the Health Department of Western Australia as “the application and combination of new and existing technologies to more precisely describe and analyse individuals and their environment, tailor preventive interventions for at-risk groups, and improve the overall health of the population” [1]. Using sequencing data of pathogens can result in unprecedented levels of speed and accuracy of contact and source investigations. Digitalizing and sharing this data across public health programs can expedite anticipatory planning and interventions [2]. These developments pose new ethical challenges, since collecting and using genomics data on pathogens to target populations for public health interventions requires negotiations between individual rights, target group interests, and the larger public welfare. While none of the relevant concerns—personal privacy risks, risks of group harms through stigmatization and blame, or population health—are foreign to public health, the efficiency and power of precision public health methods can both fuel and focus them in unprecedented ways. Here we discuss how traditional public health ethics and the ethos of genomic medicine can come together to form a hybrid ethical framework for precision public health, adapted to the big data challenges of the twenty-first century.

Public health ethical principles

Four traditional principles from public health ethics help lay the foundations for the use of precision tools like pathogen sequencing. The priority principle ensures that health issues that threaten social stability supersede individual interests, justifying interventions such as quarantining. The harm principle allows public health authorities to restrict personal liberties for disease control without the consent of individuals or groups involved, as is currently often the case for disease surveillance or contact tracing. The least intrusive means and social justice principles serve as the traditional brakes on public health's utilitarian goals. Using the least intrusive means necessary to mitigate the impact of any autonomy violations from necessary public health interventions. The social justice principle requires the burdens and benefits of public health interventions to be distributed fairly across all sectors of society, even at the expense of disease control goals [3].

In democratic societies, the translation of the traditional principles of public health ethics into public health law and policy is based on a population’s decision to voluntarily trade certain liberties for protection against health threats. For marginalized groups without a voice in that public decision-making, this trade-off may be perceived as an oppressive imposition of social risk. As phylogenetic surveillance for HIV, TB, and COVID-19 is starting to show, this problem is amplified as precision approaches to public health data-gathering make community targeting more precise and powerful [4]. This is where the ethics of precision medicine can help.

Precision medicine ethical principles

The ethics of precision medicine combines the commitments of traditional medical ethics to patient privacy and autonomy with the concerns for group health interests and disparities raised by genomic risk stratification [5]. The ethos of precision medicine focusses on the importance of personal and community control over the generation and disposition of identifiable genomic information, the need to consider the rights and interests of other people affected by a patient’s genomic information, the obligation to avoid harm by protecting the privacy of identifiable stored genomic information and the importance of professional transparency about information revealed by genomic screening, including disclosure of clinically actionable findings [6].

A hybrid framework

Precision public health ethics lies at the intersection between the clinical patient-doctor covenant of genomic precision medicine and the public decision-making that empowers action by public health authorities, thereby creating a hybrid ethical framework. In this intersection, the application of the traditional principles of public health ethics is influenced by the need to be responsive to the personalizing power of big data. While the goal of precision public health interventions remains at the level of population disease control, the focus of the ethical concern shifts from the population as a whole to at risk communities, individuals, and locations. The resulting hybrid principle of community priority entails that the risks posed by any targeted precision public health intervention should be justified by the importance of the disease burden in the targeted group [7].

The engagement of both individuals and groups in precision medicine decision-making regarding identifiable and socially potent information also affects the ways in which the Harm Principle is deployed. As precision public health targets particular locations, groups, or individuals, the need to enlist the people at risk as partners in intervention planning and implementation increases. The hybrid principle of shared authority is especially important when those targeted lack a meaningful voice in the democratic ratification of public health authority. Shared authority reflects the recognition that a socially just public health system should complement the public’s endorsement of authorizing legislation with transparent public engagement when particular groups are targeted for intervention [8].

Another important contribution of precision medical ethics to precision public health ethics is its robust commitment to information privacy, good governance of data, and professional confidentiality. In public health, the exchange of surveillance data is critical to combatting the spread of disease. The social risks of more precise information, such as whole genome sequences of pathogens linked to clinical and sociodemographic meta-data (such as concurrent infections, geographic location, immigration status, or history of incarceration) requires expanding the public health principle of least intrusive means from the domain of disease control interventions to the realm of data collection and data sharing. The hybrid least intrusive data use principle dictates that, to prevent the public disclosure of potentially stigmatizing information, all data sharing should occur within confidential contexts protected by strong data security practices and conform to relevant personal privacy laws [9].

Finally, the ethics of precision medicine embraces the commitment of public health ethics to social justice and places an emphasis on professional transparency and the trust it engenders. Transparent communication of precision public health information that is free of moralizing language will be needed to prevent inaccurate public attributions of responsibility for disease hotspots and stigmatization of people, locations, communities, or groups that are already socially marginalized. Precision public health communication will also have to be explicit about its scientific limitations and emphasize the permeability of targeted locations or communities. Just as clinical transparency about actionable genetic risks can empower patients to become involved in preventive care, proactive transparency about precision public health efforts can help communities to become active partners in disease control efforts [10].

Conclusions and outlook

In conclusion, most laws and guidelines that govern public health infectious disease control efforts were developed under historical conditions that greatly differ from our current societal context. The speed, precision, and efficiency of big data, digital technologies, and pathogen sequencing offer public health opportunities but come with the responsibility to adapt its practices to a world increasingly committed to privacy, respect for human rights in health matters, and social justice. One way forward for precision public health ethics is through a framework that integrates the key moral commitments and ethical requirements of precision medicine and traditional public health (Table 1). The recommendations based on this hybrid approach can help generate awareness of the ethical issues at stake and ensure that the implementation of precision public health actions is in line with bioethical principles, protect public health, promote solidarity, equity, and social justice, and empower and engage patients and their communities.

Table 1 The four intersectional elements of precision public health ethics

Availability of data and materials

Not applicable


  1. Weermanthi T, Dawkins H, Baynam G, Bellgard M, Gudes O, Semmens J. Precision public health. Front Public Health. 2018;6:121.

    Article  Google Scholar 

  2. Ladner JT, Grubaugh ND, Pybus OG, Andersen KG. Precision epidemiology for infectious disease control. Nat Med. 2019;25(2):206–11. Epub 2019 Feb 6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Childress J, Faden R, Gaare R, et. al. Public health ethics: mapping the terrain. J. Law Med Ethics 2002; 30: 170–178.

  4. Molldrem S, Smith A. Reassessing the ethics of molecular HIV surveillance in the era of cluster detection and response: toward HIV data justice. AJOB. 2020;20(10):10–23.

    PubMed  Google Scholar 

  5. Meagher K, Mcgowan M, Settersten R, Fishman J, Juengst E. Precisely where are we going? Charting the new terrain of precision prevention” Ann. Rev. of Human of Genomics and Human Genetics 2017; 18:

  6. Kao AC, Ed., Ethics in precision medicine: special issue. AMA Ethics J 2018; 20;9: E793–E910.

  7. Dawson L, Benbow N, Fletcher F, et. al. Addressing ethical challenges in US-based HIV phylogenetic research. J Inf Dis 2020; DOI:

  8. Johnson SB, Parker M. The ethics of sequencing infectious disease pathogens for clinical and public health. Nat Rev Genet. 2019;20(6):313–5.

    Article  CAS  PubMed  Google Scholar 

  9. Milne R. Societal considerations in host genome testing for COVID-19. Genet Med. 2020;8:1–3. Online ahead of print.

    Article  CAS  Google Scholar 

  10. Jackson C, Gardy JL, Shadiloo HC, Silva DS. Trust and the ethical challenges in the use of whole genome sequencing for tuberculosis surveillance: a qualitative study of stakeholder perspectives. BMC Medical Ethics. 2019;20:43.

    Article  Google Scholar 

Download references


The authors would like to thank the following colleagues for helpful discussions of the ideas presented here: Dario García de Viedma, Conor Meehan, Inaki Comas, Tim H. Heupink, Elise De Vos, Wouter Arrazola de Oñate, Vanessa Mathys, Pieter-Jan Ceyssens, Guido Groenen, Fernando González-Candelas, Annemie Forier.


This work was supported by the Research Foundation Flanders (FWO) under Odysseus grant N° G0F8316N and TBM grant N° T001018N. The funding agency played no role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.

Author information

Authors and Affiliations



EJ and AvR co-conceived and co-developed the analysis. EJ drafted the text and AvR made substantive editorial contributions to the writing. The authors read and approved the final manuscript.

Corresponding author

Correspondence to Eric T. Juengst.

Ethics declarations

Ethics approval and consent to participate

Not applicable

Consent for publication

Not applicable

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Juengst, E.T., Van Rie, A. Transparency, trust, and community welfare: towards a precision public health ethics framework for the genomics era. Genome Med 12, 98 (2020).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: